Loading...Loading...Wednesday, Illumina Inc ILMN acquired Fluent BioSciences to expand its reach in single-cell analysis and multiomics research for an undisclosed consideration.Amid this M&A deal, 10x Genomics, Inc TXG shares are trading lower.William Blair writes that Fluent’s PIPseq single-cell technology does not require an instrument, and costs per cell is at least 50% less than 10x and is the cheapest on the market, citing a recent bioRxiv preprint.William Blair highlights that cost reduction has beco ...